EndoQuest Robotics™

We are proud to announce our Endoluminal Surgical (ELS) System has received Investigational Device Exemption (IDE) approval to initiate clinical trials in the U.S. We look forward to collaborating with champions of minimally invasive techniques to demonstrate the power of endoluminal, scar-free surgery. Read the full announcement in our latest release:  https://lnkd.in/gJa-vB3s Through our revolutionary flexible robotic system, we are transcending the limitations of current technology and redefining what’s possible in surgery. Hiroyuki Aihara, MD, PhD | Brigham and Women's Hospital Eric Haas | HCA Houston Healthcare Matthew Albert | AdventHealth Orlando Norio Fukami | Mayo Clinic Scottsdale Josh Sommovilla | Cleveland Clinic Silvana Perretta Christopher C. Thompson, MD MSc FASGE FACG AGAF IRCAD www.endoquestrobotics.com The Endoluminal Surgical System is under development, is not FDA cleared, and is not for commercial sale in the United States.

We are proud to announce our Endoluminal Surgical (ELS) System has received Investigational Device Exemption (IDE) approval to initiate clinical trials in the U.S. We look forward to collaborating with champions of minimally invasive techniques to demonstrate the power of endoluminal, scar-free surgery. Read the full announcement in our latest release:  https://lnkd.in/gJa-vB3s Through our revolutionary flexible robotic system, we are transcending the limitations of current technology and redefining what’s possible in surgery. Hiroyuki Aihara, MD, PhD | Brigham and Women's Hospital Eric Haas | HCA Houston Healthcare Matthew Albert | AdventHealth Orlando Norio Fukami | Mayo Clinic Scottsdale Josh Sommovilla | Cleveland Clinic Silvana Perretta Christopher C. Thompson, MD MSc FASGE FACG AGAF IRCAD www.endoquestrobotics.com The Endoluminal Surgical System is under development, is not FDA cleared, and is not for commercial sale in the United States.

The next chapter of surgery is on the horizon. We are excited to announce submission of our Investigational Device Exemption (IDE) application to the FDA to initiate a clinical trial for the Endoluminal Surgical (ELS) System.  https://lnkd.in/g5ND6MqS This significant milestone reflects the tireless effort of the team at EndoQuest with a passion for making endoluminal, scar-free surgery a reality. Thank you to our clinical partners and principal investigators for their continued support and shared vision for the future of medicine. Following the advancements of minimally invasive surgery from laparoscopy and rigid robotics, we look forward to driving the next evolution in patient outcomes. Hiroyuki Aihara, MD, PhD | Brigham and Women's Hospital Eric Haas | HCA Houston Healthcare Matt Albert | AdventHealth Orlando Norio Fukami | Mayo Clinic Scottsdale Josh Sommovilla | Cleveland Clinic Silvana Perretta Christopher C. Thompson, MD MSc FASGE FACG AGAF IRCAD www.endoquestrobotics.com The Endoluminal Surgical System is under development, is not FDA cleared, and is not for commercial sale in the United States.

Congratulations to Dr. Nicha Srisuworanan of Brigham & Women's Hospital for her selection as a finalist in this year's prestigious Hamlyn Symposium on Medical Robotics. This international competition attracts the leading surgical robotics programs from around the world to showcase innovative new ideas and platforms. Award categories include best innovation, application, and design. Hamlyn Symposium. https://lnkd.in/e5iEcpT8

If you're attending SRS2024 this week and want to test your endoluminal robotic skills, join us at Booth A231/233 and check out our portable Flexible Robotic System Simulator developed with our amazing simulation partner, VirtaMed. www.endoquestrobotics.com. The Flexible Robotic Surgical System is under development, is not FDA cleared, and is not for commercial sale in the United States.

If you're going to SRS2024 this week in Orlando and want to experience the future of robotic surgery, join us at Booth A231/233 to learn more about the Flexible Robotic System we are developing to enable Scar-Free Surgery. www.endoquestrobotics.com The Flexible Robotic Surgical System is under development, is not FDA cleared, and is not for commercial sale in the United States.

Congratulations to Dr. Nicha Srisuworanan of Brigham & Women's Hospital for receiving ASGE's prestigious "Best of the Best" award for her presentation on a pre-clinical feasibility study titled “ROBOTIC ENDOLUMINAL SLEEVE GASTROPLASTY: PROCEDURE DEVELOPMENT AND TECHNICAL FEASIBILITY” at this year's DDW Meeting In Washington, DC. For more information about EndoQuest's Flexible Robotic System, visit www.EndoQuestRobotics.com The Flexible Robotic Surgical System is under development, is not FDA cleared, and is not for commercial sale in the United States.

Thank you Dr. Daniel Szvarca of Brigham & Women's Hospital for presenting the promising results from a pre-clinical comparison titled "ROBOT-ASSISTED VERSUS CONVENTIONAL ENDOSCOPIC SUBMUCOSAL DISSECTION FOR COLONIC LESIONS: A RANDOMIZED, CONTROLLED, BOVINE COLON STUDY" at this year's DDW Meeting in Washington, DC. To learn more about EndoQuest's Flexible Robotic System, visit www.EndoQuestRobotics.com The Flexible Robotic Surgical System is under development, is not FDA cleared, and is not for commercial sale in the United States.

EndoQuest Robotics is excited to announce that Dr. Nicha Srisuworanan of Brigham & Women's Hospital will be presenting the results from a pre-clinical feasibility study titled “ROBOTIC ENDOLUMINAL SLEEVE GASTROPLASTY: PROCEDURE DEVELOPMENT AND TECHNICAL FEASIBILITY” at this year's DDW Meeting between 2:00 and 3:30 PM on Monday, May 20th in Ballroom C at the Walter E. Washington Convention Center and online. Don't miss the chance to learn more about the amazing capabilities of our Flexible Robotic System! https://lnkd.in/e5iEcpT8 The Flexible Robotic Surgical System is under development, is not FDA cleared, and is not for commercial sale in the United States.

EndoQuest Robotics is excited to announce that Dr. Daniel Szvarca of Brigham & Women's Hospital will be presenting the results from a pre-clinical comparison titled "ROBOT-ASSISTED VERSUS CONVENTIONAL ENDOSCOPIC SUBMUCOSAL DISSECTION FOR COLONIC LESIONS: A RANDOMIZED, CONTROLLED, BOVINE COLON STUDY" at this year's DDW Meeting at 4:13 PM on Sunday, May 19th in Room 143ABC at the Walter E. Washington Convention Center and online. Don't miss the chance to learn more about the potential benefits of our Flexible Robotic System! https://lnkd.in/e5iEcpT8 The Flexible Robotic Surgical System is under development, is not FDA cleared, and is not for commercial sale in the United States.